Mel bridges is emblematic of some of the problems of the biotech sector. Professional director who is spread too thin and no great passion for some/most of the comapnies where he is taking a fee. At least he has reasonable skin in the game at alchemia - which is not the case for all companies where he is taking a fee.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable